Shingles Vaccine (Shingrix) & Contact with Children: No Risk

You do not need to avoid children after receiving the recombinant zoster vaccine (Shingrix).

Why It’s Safe

  • Shingrix is non-live—contains glycoprotein E + adjuvant (AS01B). No virus to shed.
  • Even the older live attenuated vaccine (Zostavax, discontinued in US) posed theoretical but extremely low transmission risk; no documented cases of vaccine-strain varicella transmission to contacts.

Common Side Effects (Self-Limited)

  • Injection site pain, redness, swelling.
  • Fatigue, myalgia, headache, fever (1–3 days).

Who Should Get It

  • Adults ≥50 years (2 doses, 2–6 months apart).
  • Immunocompromised adults ≥19 years.

No precautions needed around infants, pregnant women, or immunocompromised individuals. Vaccination protects you—and indirectly them by reducing your shingles risk.

Pediatrics - Related Articles